We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00193024
First Posted: September 19, 2005
Last Update Posted: May 3, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Aventis Pharmaceuticals
Pharmacia and Upjohn
Information provided by:
SCRI Development Innovations, LLC
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2004
  Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)
Publications:

To Top